← All Sponsors
SPONSOR

Staidson (Beijing) Biopharmaceuticals Co., Ltd

Total Trials
1
Recruiting
1
Phases
Phase 3
Conditions studied: Acute Respiratory Distress Syndrome (ARDS)
NCT07208591 Phase 3
Recruiting

To Evaluate The Safety and Efficacy of STSA-1002 Injection in Patients With Acute Respiratory Distress Syndrome

Acute Respiratory Distress Syndrome (ARDS)
China View Trial →